Related Experiment Video
Updated: Jun 14, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
How I treat hemochromatosis
1University Hospital, University of Western Ontario, London, ON, Canada. padams@uwo.ca
Blood
|March 24, 2010
Summary
Hereditary hemochromatosis causes excess iron buildup. Phlebotomy (blood removal) is the main treatment to deplete iron stores and prevent organ damage, alongside dietary changes and voluntary blood donation.
Area of Science:
- Genetics and Hematology
- Metabolic Disorders
- Internal Medicine
Background:
- Hemochromatosis is a prevalent genetic condition characterized by progressive iron overload.
- Excess iron accumulation can lead to severe dysfunction in organs like the liver and heart.
- Therapeutic strategies aim to reduce body iron levels and mitigate organ damage.
Purpose of the Study:
- To outline the indications and monitoring protocols for phlebotomy in hemochromatosis management.
- To discuss adjunctive therapies, including dietary and pharmacologic interventions, to reduce iron absorption.
- To explore the potential role of voluntary blood donation in managing iron overload.
Main Methods:
- Review of current therapeutic guidelines and clinical practices for hemochromatosis.
- Discussion of phlebotomy as the cornerstone of iron depletion therapy.
- Analysis of strategies to minimize iron absorption and support maintenance therapy.
Main Results:
- Phlebotomy is the primary treatment for normalizing body iron stores in hemochromatosis.
- Effective monitoring is crucial for both initial iron depletion and long-term maintenance.
- Dietary and pharmacologic approaches can supplement phlebotomy by reducing iron absorption.
Conclusions:
- Phlebotomy is the essential therapy for managing iron overload in hemochromatosis.
- A comprehensive approach combining phlebotomy, monitoring, and absorption reduction is key.
- Voluntary blood donation may play a supportive role in iron management strategies.
More Related Videos
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:22Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.